Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05694637 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Botswana Smoking and Abstinence Reinforcement Trial

Study acronym: BSMART
StatusEnrolling by Invitation
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 10 to 15v8
  2. Collaborators revised (3)v7
  3. Study sites: 5 to 10v6
  4. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Start date changed from estimate of Jul 15, 2023 to Jul 25, 2023
    v5
  5. Start date: Jul 1, 2023 to Jul 15, 2023v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: May 1, 2023 to Jul 1, 2023v3
  2. Start date: Mar 1, 2023 to May 1, 2023v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Many people living with HIV in southern Africa, specifically Botswana use tobacco products. Using tobacco makes some of the effects of HIV worse and even causes excess deaths. The investigators plan to use an intervention called Screening, Brief Intervention and Referral to Treatment (SBIRT) to help people to quit smoking and also a drug called varenicline. Apart from helping people to stop smoking, the investigators will also test to see how task shifting can be used to help people stop smoking in a sustainable way. Finally, the investigators will estimate the cost of the intervention.
Trial Details
NCT Number NCT05694637
Lead Sponsor University of Maryland, Baltimore
Collaborators: University of Maryland, Baltimore County, University of Maryland, College Park, University of Chicago
Conditions
(from sponsor)		 Smoking Cessation, Hiv
Related terms Acquired Immunodeficiency Syndrome, Smoking Cessation
Enrollment 750 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov